1-O-Octadecyl-2-O-benzyl-sn-glyceryl-3-phospho-GS-441524 (V2043). Evaluation of Oral V2043 in a Mouse Model of SARS-CoV-2 Infection and Synthesis and Antiviral Evaluation of Additional Phospholipid Esters with Enhanced Anti-SARS-CoV-2 Activity

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

(2022) Jennifer Hammond et al.   NEW ENGLAND JOURNAL OF MEDICINE

Recommendations for the management of drug‐drug interactions between the COVID‐19 antiviral nirmatrelvir/ritonavir (Paxlovid ® ) and comedications

(2022) Catia Marzolini et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Mutations in the SARS-CoV-2 RNA dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms

(2022) Laura J. Stevens et al.   Science Translational Medicine

The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants

(2022) Liu Cao et al.   Science Translational Medicine

Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice

(2022) Alexandra Schäfer et al.   Science Translational Medicine

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

(2022) Qian Wang et al.   NATURE

The Vaccine-Hesitant Moment

(2022) Heidi J. Larson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Covid-19 Vaccines — Immunity, Variants, Boosters

(2022) Dan H. Barouch   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 3CL pro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376

(2022) Emmanuel Heilmann et al.   Science Translational Medicine

Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir

(2022) Sho Iketani et al.   NATURE

VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19

(2022) Zhujun Cao et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 Infection after Vaccination in Health Care Workers in California

(2021) Jocelyn Keehner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rethinking Remdesivir: Synthesis, Antiviral Activity, and Pharmacokinetics of Oral Lipid Prodrugs

(2021) Robert T. Schooley et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation

(2021) Kirk Chan-Tack et al.   ANTIVIRAL RESEARCH

Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2

(2021) Yuanchao Xie et al.   CELL RESEARCH

Efficient incorporation and template-dependent polymerase inhibition are major determinants for the broad-spectrum antiviral activity of remdesivir

(2021) Calvin J. Gordon et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

(2021) Angélica Jayk Bernal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

(2021) Robert L. Gottlieb et al.   NEW ENGLAND JOURNAL OF MEDICINE

Broad-Spectrum In Vitro Antiviral Activity of ODBG-P-RVn: An Orally-Available, Lipid-Modified Monophosphate Prodrug of Remdesivir Parent Nucleoside (GS-441524)

(2021) Michael K. Lo et al.   Microbiology Spectrum

Remdesivir for the Treatment of Covid-19 — Preliminary Report

(2020) John H. Beigel et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice

(2020) Sarah R. Leist et al.   CELL

A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures

(2020) Kenneth H. Dinnon et al.   NATURE

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

(2016) Travis K. Warren et al.   NATURE

Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs

(2014) Ugo Pradere et al.   CHEMICAL REVIEWS

Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: Current state of the art

(2009) Karl Y. Hostetler   ANTIVIRAL RESEARCH

Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue

(2008) Herbert Schott et al.   BIOORGANIC & MEDICINAL CHEMISTRY